A Novel Target Delineation Scheme in High-grade Glioma Patients: a Randomized Single-blind Clinical Trial

Clinical trial NCT06215495 · RECRUITING

Trial details

NCT number: NCT06215495
Sponsor: Zhujiang Hospital
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Radiation Toxicity MRI Simulated Positioning High Grade Glioma Progression-free Survival Overall Survival

Start date: 2024-02-18
Primary completion: 2027-05-28
Enrollment: 88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.